OCGN stock is a speculative bet. An approval of Covaxin by the FDA would boost OCGN stock. However, the firm’s revenue potential is limited. Read More
Ocugen Stock Is a Speculative Covid-19 Vaccine Bet
2021-05-28T17:46:04-04:00May 28th, 2021|
Related Posts
-
The Top 3 Real Estate Stocks to Buy in April 2024
April 25th, 2024 -
Is QuantumScape Stock Going to $6? 1 Wall Street Analyst Thinks So.
April 25th, 2024 -
Pepsi Tops Estimates Despite A Weakened Domestic Market
April 25th, 2024